Ranbaxy Bids For Second Look In Lipitor Feud
Swiping back in the battle over Pfizer Inc.'s Lipitor, Indian drug maker Ranbaxy Laboratories Ltd. on Wednesday asked a U.S. appeals court to reconsider part of a ruling that would block...To view the full article, register now.
Already a subscriber? Click here to view full article